[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360647-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-360647-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","omics-data-integration-focusing-on-molecular-biomarkers-for-cancers-and-diseases","Omics Data Integration: Focusing on Molecular Biomarkers for Cancers and Diseases","","Rapid advances in high-throughput sequencing, advanced mass spectrometry, and quantitative imaging have exponentially expanded molecular datasets, making multi-omics integration essential for systems-level interpretation. The editorial explains why omics layers rarely fully correlate, attributing discrepancies to biological complexity rather than only technical limitations. It highlights how integrative transcriptomic, epigenomic, proteomic, metabolomic, and imaging features can yield more robust biomarkers for cancer and disease. It also addresses standardization, computational harmonization, and the challenge of linking molecular signatures to clinical endpoints.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/omics-data-integration-focusing-on-molecular-biomarkers-for-cancers-and-diseases/360647/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/omics-data-integration-focusing-on-molecular-biomarkers-for-cancers-and-diseases/360647.png","ImageObject",300,407,{"name":42,"@type":43},"Jasmine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What methodological challenges are emphasized for translating multi-omics research?","Question",{"text":63,"@type":64},"The editorial stresses standardizing datasets and analysis methods, harmonizing heterogeneous data using computational techniques, and the ongoing difficulty of linking molecular signatures to phenotypic traits and clinically relevant endpoints.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},360647,1791016223,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,102,106,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":99,"show_sort_weight":100,"slug":101},"Healthcare",40,"healthcare",{"id":103,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":104,"slug":105},8,30,"research-report",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},9,"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":103,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":94,"language":131,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":12,"update_tm":135,"read_time":136,"preview_page_count":33,"preview_urls":137},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Editorial  \nOmics Data Integration: Focusing on Molecular Biomarkers for Cancers and Diseases  \nLucia De Salvo 1 and Cinzia Franchin 1,2, *  \nReceived: 29 May 2026  \nRevised: 3 June 2026  \nAccepted: 5 June 2026  \nPublished: 10 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy; [lucia.desalvo@studenti.unipd.it](lucia.desalvo@studenti.unipd.it)  \n2 Mass Spectrometry Facility (MS@DSF), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy  \n* Correspondence: [cinzia.franchin@unipd.it](cinzia.franchin@unipd.it)  \n1. Introduction  \nIn recent years, rapid technological progress in high-throughput sequencing, advanced mass spectrometry, and quantitative imaging has profoundly reshaped biomedical and clinical research. As a consequence, the sheer volume and diversity of available molecular data have grown exponentially, bringing genomics, transcriptomics, proteomics, metabolomics, lipidomics, epigenomics, and metagenomics into routine scientific practice [1] . While each omics layer offers a valuable but partial view of biological systems, it is the integration of these layers that ultimately enables a comprehensive, systems-level interpretation of molecular processes. This transition from single-omic to multi-omic analysis has become a hallmark of modern systems biology and is regarded as a key driver for the discovery of more accurate and functionally informative biomarkers [2] .  \nOne of the strengths of the multi-omics approaches is their complementarity of omics technologies. It is therefore noteworthy that outputs from various, yet closely related molecular layers rarely fully correlate. For example, transcriptomic and proteomic data often only partially coincide, as gene expression does not uniformly lead to proportional protein abundance because of post-transcriptional regulation, protein turnover, and degradation mechanisms [3,4] . Therefore, inconsistency of the omics layers is not a technical issue, but rather an indication of the complexity of cellular biology. From a practical point of view, one omics layer is a limited choice and thus conclusions may end up being incomplete or misleading, which could explain why some single-omic biomarkers fail in clinical settings [5] . However, differences across omics layers can themselves provide valuable biological insights, elucidating functionally active pathways, post-transcriptional regulatory mechanisms, and cellular responses to disease or stress. A key reason integrative multi-omics approaches are critical to gain a more comprehensive understanding of disease biology could be attributed to the lack of perfect concordance between genomics, transcriptomics, proteomics, and metabolomics [5,6] .  \nIntegrated multi-omics strategies have been particularly transformative in the field of biomarker discovery. Diseases such as cancer, neuroinflammatory disorders, chronic inflammatory conditions or metabolic syndromes are characterized by complex interactions spanning gene regulation, protein networks, metabolic fluxes, and environmental contributions. Relying on a single type of molecular information is often insufficient to fully capture this complexity. Instead, combining transcriptomic signatures with epigenomic marks, proteomic pathways, metabolomic profiles, or imaging-based phenotypes can generate biomarkers that are not only more robust, but also more likely to reflect causal biological mechanisms. Advances in computational biology, machine learning, structural modeling  \nand network science have further expanded the analytical landscape, making it possible to integrate multimodal data in increasingly sophisticated ways [7,8] .  \nT","cbCaihIJfmJkDaeG","https://ap.wps.com/l/cbCaihIJfmJkDaeG","pdf",165082,"English","# Introduction\n## Transition to multi-omic analysis\n## Strengths and inconsistency across omics layers\n## Impact on biomarker discovery\n## Translational and methodological challenges\n# Overview of Published Papers\n## Exploring regulatory networks in prostate cancer through integration","[{\"question\":\"What methodological challenges are emphasized for translating multi-omics research?\",\"answer\":\"The editorial stresses standardizing datasets and analysis methods, harmonizing heterogeneous data using computational techniques, and the ongoing difficulty of linking molecular signatures to phenotypic traits and clinically relevant endpoints.\"}]","Omics Data Integration: Focusing on Molecular Biomarkers for Cancers and Diseases | PDF",1790140840,15,[138,142,146,150],{"page_no":22,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87991ccd2b983abedb857b2074fbd4ca.webp",983,1390,{"page_no":26,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ffb90d4a88fc1a30bcce2532d577d2d.webp",982,1388,{"page_no":30,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73ad4a93e36b75b8bfb479d8383b3a1f.webp",981,1387,{"page_no":33,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/386fa947e43be100157adf30c418b36c.webp",980,1385]